Tool Calling and Plugins for Phase I Clinical

Data Characteristics

Phase I clinical pharmacovigilance data primarily originates from subject symptom records, laboratory test results, physical examination data, and investigator-reported Adverse Drug Event (ADE) reports during clinical trials. This data is typically stored in Electronic Data Capture (EDC) systems or entered via paper Case Report Forms (CRF). Data updates are frequent, usually recorded immediately after each visit or adverse event occurrence. Document structure is highly standardized, adhering to ICH GCP guidelines. This includes adverse event report forms, subject diaries, and concomitant medication records. Field content is rigorous, covering adverse event descriptions, occurrence dates, severity, outcomes, and assessments of causality with the study drug. The MedDRA coding system standardizes disease and adverse reaction terminology. Dosage units are commonly milligrams (mg), micrograms (μg), or milliliters (mL).

Constraints on Tool Calling and Plugins

The high update frequency and standardized structure of Phase I clinical data require tool calling to support real-time or near real-time data synchronization. This ensures timely adverse event monitoring. The specialized nature of MedDRA coding means plugins need built-in or integrated medical terminology libraries to accurately parse and generate relevant terms. Data volume is relatively small but highly sensitive. This demands specific requirements for API call concurrency and data transmission security. Standardized document structures facilitate data extraction and processing using predefined templates. However, minor differences may exist across trial protocols, requiring plugins to adapt with flexibility. Processing subjective fields, such as causality assessments for adverse events, requires tools to infer context or prompt for human intervention when necessary.

Configuration Guidelines

Configuration Item	Recommended Value	Rationale
`maxConcurrentCalls`	`5–10`	Phase I clinical data volume is relatively small. This avoids excessive concurrency pressure on EDC systems.
`timeoutSeconds`	`600 seconds`	Ensures response times for complex data processing and external MedDRA coding service calls.
`payloadSizeLimitMB`	`10 MB`	Accommodates detailed text descriptions and small attachments potentially included in a single adverse event report.
`meddraVersion`	`Latest Stable Version`	Ensures adverse event coding aligns with the latest medical terminology standards.
`dataFreshnessThreshold`	`1 hours`	Guarantees real-time adverse event data for timely detection of potential safety signals.
`errorRetryAttempts`	`3 times`	Addresses transient external service failures, improving data processing stability.

Common Pitfalls

A plugin calling an external API receives an HTTP 503 Service Unavailable error. This occurs when the concurrent request volume exceeds the capacity of the EDC system or MedDRA coding service.
Key fields in adverse event reports, such as causality assessment or outcome, are empty. This is due to incorrect data mapping rules, preventing accurate information extraction from unstructured text.
A plugin execution times out, returning an Execution Timeout error. This typically occurs because an external service responds slowly or MedDRA coding query efficiency is not optimized when processing text with extensive medical terminology.

Verification Steps

After calling the plugin, check the adverse event code field in the returned result. Confirm it complies with MedDRA standards and matches the original description.
Simulate multiple concurrent requests. Observe system logs to ensure no HTTP 429 Too Many Requests or HTTP 503 errors appear.
Review the processed adverse event reports. Verify that key fields, such as drug causality and adverse event outcome, are accurately extracted and populated.

The values provided are common starting points. Measure them against specific samples.

Question material comes from public community discussions. Configuration values are common starting points and should be measured against your own samples. Verified on 2026-09-21.